Close Menu

At first glance it may not seem like such a big deal to sell flounder and call it cod. But such "seafood fraud" is being taken very seriously by the US Food and Drug Administration, which is now using genetic testing and a database of "DNA bar codes" to combat these fishy crimes, reports Scientific American's Clare Leschin-Hoar.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.